Increasing resistance in commensal Escherichia coli, Bolivia and Peru [2]

Emerging Infectious Diseases

Volumn 14, Issue 2, 2008, Pages 338-340

  Bartoloni, Alessandro ^a,g   Pallecchi, Lucia ^b   Fiorelli, Costanza ^a   Di Maggio, Tiziana ^b   Fernandez, Connie ^c   Villagran, Ana Liz ^d   Mantella, Antonia ^a   Bartalesi, Filippo ^a   Strohmeyer, Marianne ^a   Bechini, Angela ^a   Gamboa, Herlan ^d   Rodriguez, Hugo ^c   Kristiansson, Charlotte ^e   Kronvall, Göran ^e   Gotuzzo, Eduardo ^f   Paradisi, Franco ^a   Rossolini, Gian Maria ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Hospital Apoyo Yurimaguas   (Peru)

^d Servicio Departamental de Salud Santa Cruz   (Bolivia)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BOLIVIA; COMMENSAL ESCHERICHIA COLI; HUMAN; INFANT; INTESTINE INFECTION; LETTER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PERU; PRESCHOOL CHILD;

EID: 38949138109     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1402.070138     Document Type: Letter

References (10)

1. World Health Organization. Global strategy for containment of antimicrobial resistance [cited 2006 Nov 10]. Geneva: The Organization; 2001. Available from http://www.who.int/drugresistance/en
2. Bartoloni A, Pallecchi L, Benedetti M, Fernandez C, Vallejos Y, Guzman E, et al. Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis. 2006;12:907-13.
3. Pallecchi L, Bartoloni A, Fiorelli C, Mantella A, Di Maggio T, Gamboa H, et al. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli from healthy children from low-resource settings of Latin America. Antimicrob Agents Chemother; 2007;51:2720-5
4. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med. 2006;119:S20-8.
5. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006;6:629-40.
6. Johnson JR, Kuskowski MA, Menard M, Gajewski A, Xercavins M, Garau J. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis. 2006;194:71-8.
7. Lautenbach E, Fishman NO, Metlay JP, Mao X, Bilker WB, Tolomeo P, et al. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis. 2006;194:79-85.
8. Rodriguez-Baño J, Paterson DL. A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin Infect Dis. 2006;42:935-7.
9. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis. 2006;42:925-34.
10. Collignon P, Angulo FJ. Fluoroquinolone-resistant Escherichia coli: food for thought. J Infect Dis. 2006;194:8-10.